Skip to content
Book
Clinical specialist

Gail Humble, MD

Non-Surgical Cosmetic Medicine, Regenerative Aesthetics, Klotho Research

Non-surgical cosmetic medicine, collagen-stimulating injectables and klotho-focused regenerative treatments from a physician in practice since the 1990s

4.4 · 7 reviews
Identity, California license, federal provider record, practice address and authorship sourcedReviewed

At a glance

Professional status
California Physician and Surgeon license C40624 · Current through 2028-05-31California Physician and Surgeon license C40624

Medical Board of California public license file, extract dated 2026-09-01

Federal provider record
NPI 1285902080, carrying license c40624NPI 1285902080
Board certification
Anesthesiology, plus the American Board of Laser Medicine and Surgery

Stated by her practice and Klotho Skin biographies

Practice
Gail Humble, M.D. · Aesthetic Anti-Aging Institute · Mill ValleyGail Humble, M.D.
Company
Klotho Skin · founder and chief executiveKlotho Skin
Visit type
In person
New patients
Accepting patients
Languages
English

About

Gail Humble is a California-licensed physician who built her career in non-surgical cosmetic medicine. She studied genetics at UC Davis, earned her medical degree at the University of Texas Medical Branch in Galveston, and completed a general-surgery internship and an anesthesiology residency at USC before moving into cosmetic practice. She co-investigated Sculptra's FDA clinical trials and has published on facial volume restoration. Her klotho work, including patents on engineering stem cells to over-express the gene, led her to found Klotho Skin, which she leads as chief executive.

Approach

Signature approach

Humble opens every treatment with an educational consultation that walks the patient through the regenerative biology before a protocol is chosen. Her own emphasis is collagen-stimulating injectables such as Sculptra, where she did early trial work, alongside volume restoration and a klotho-based program that starts with a lab test.

What sets them apart

  • Early Sculptra work. She served as a co-investigator on Sculptra's FDA clinical trials and principal investigator on later studies.
  • Genetics training. A genetics degree and patents on klotho-engineered stem cells sit behind her regenerative focus.
  • Published author. First author of a 2025 pilot study of a topical klotho serum and senior author of a 2026 paper on the same approach.

Focus

Specialties

Aesthetic MedicineRegenerative Medicine

Training

Education

  • BS, Genetics
    University of California, Davis
  • MD
    University of Texas Medical Branch, Galveston
  • MD
    University of Texas Medical Branch School of Medicine (1981)

Residency

  • Anesthesiology
    University of Southern California/Los Angeles General Medical Center (1982–1984)
  • Anesthesiology
    University of Southern California

Board certifications

  • Anesthesiology

    American Board of Anesthesiology

  • Laser Medicine and Surgery

    American Board of Laser Medicine and Surgery

Additional certifications

  • American Board of Laser Medicine and Surgery certification

    American Board of Laser Medicine and Surgery

    A voluntary certifying body for laser medicine, separate from the specialty boards of the American Board of Medical Specialties. Stated by her practice and company biographies.

  • Fellow

    Aesthetic Anti-Aging Congress

NPI
1285902080

Protocols

  • Sculptra
  • Renuva
  • Microneedling with klotho complex
  • Klotho testing
  • Platelet Rich plasma

Published work

Practice

Elsewhere

Before You Book

  • Credential fit. Her board certification is in anesthesiology and she has practiced cosmetic medicine exclusively since residency; ask which training applies to your treatment.
  • Commercial tie. She founded and leads Klotho Skin, and was first author of the 2025 study the company cites for its serum.
  • Klotho evidence. The strongest klotho findings come from mouse genetics; ask what has been measured on the finished product.

Specialty scope, commercial ties and the klotho evidence

California licenses Humble as a physician and surgeon. Her board certification is in anesthesiology, and she describes having specialized exclusively in non-surgical cosmetic medicine since residency.

She is founder and chief executive of Klotho Skin and first author of the 2025 Journal of Drugs in Dermatology pilot study the company cites for its serum: sixteen women, twelve weeks, no comparison group, with the authors calling for large-scale studies. She is senior author of a 2026 paper whose lead author sits on the Klotho Skin board.

The klotho gene's longevity findings come from mouse genetics, in which disrupting the gene produced an aging-like syndrome and over-expressing it extended lifespan. The treatments apply medium from cells engineered to produce the protein to the skin, so a patient can ask what has been measured on the finished product.

Reviews

HealthgradesChecked
RealSelf4.4(7 reviews)Checked

Editorial summary

Most reviews describe satisfaction with cosmetic results, treatment recommendations and personal attention. One review reports dissatisfaction with excessive facial volume after treatment.

What people mention

  • Satisfaction with cosmetic results5 mentions
    positive
  • Personal attention, availability or follow-up2 mentions
    positive
  • Treatment selection and discussion of options3 mentions
    mixed
  • Unwanted facial volume1 mention
    negative

Research record

Reviewed

Identity, California license, federal provider record, practice address and authorship sourced

California's September 2026 public license file lists Physician and Surgeon C40624 as Current with a Mill Valley address of record matching her practice. CMS NPPES record 1285902080 carries the same license number, and PubMed records her authorship.

If a role, credential, access route or relationship has changed, contact Longevity.io with a current primary source.

Researched by Longevity.io